Form 4: Hims & Hers CFO Sells Over 23,000 Shares Under Pre-Arranged Trading Plan

Hims & Hers Health, Inc.'s Chief Financial Officer, Oluyemi Okupe, sold 23,107 shares of Class A Common Stock for approximately $47.25 per share, executed under a Rule 10b5-1 trading plan.

Summary

• Oluyemi Okupe, Chief Financial Officer of Hims & Hers Health, Inc. (HIMS), sold 23,107 shares of the company's Class A Common Stock.
• The transaction occurred on June 23, 2025.
• The shares were sold at an average weighted price of $47.2483, with prices ranging from $47.15 to $47.43.
• Following the sale, Mr. Okupe directly beneficially owns 63,222 shares and indirectly owns 70,575 shares through the Oluyemi Okupe Separate Property Trust.
• The sale was conducted pursuant to a Rule 10b5-1 trading plan adopted by Mr. Okupe on May 31, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While insider selling can sometimes be viewed negatively, the fact that it was conducted under a pre-arranged Rule 10b5-1 plan mitigates concerns that it's based on new, adverse information. It's a routine liquidity event for an executive.

Positives

• The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, indicating it was not a reaction to new, negative information but rather a scheduled liquidity event for the executive.

Negatives

• A significant sale of 23,107 shares by a key executive (CFO) could be perceived negatively by some investors, as it reduces insider ownership.

Risks

• No specific risks are mentioned in this Form 4 filing beyond the inherent perception of insider selling, which some investors might interpret as a lack of confidence, despite the 10b5-1 plan.

Future Outlook

This document does not contain any forward-looking statements or guidance.

Industry Context

This Form 4 filing details an individual executive's stock transaction and does not provide broader industry context or trends. Insider transactions are a common occurrence across all industries, often for personal financial planning or diversification.

Comparison to Industry Standards

• This document does not provide information that allows for a comparison to global benchmarks or specific comparable companies/projects. Insider trading reports are specific to the individual and company.

Related Party Transactions

• The sale of shares by the Chief Financial Officer is a related party transaction, as it involves a key executive of the company. However, it is a standard insider sale reported on Form 4, not a complex related party dealing typically disclosed in other filings.

Stakeholder Impact

• Shareholders: The sale reduces the CFO's direct ownership, which some shareholders might interpret as a lack of confidence, though the 10b5-1 plan mitigates this. It provides liquidity for the executive.
• Employees, Customers, Suppliers, Creditors: This specific filing is unlikely to have a direct or immediate impact on these stakeholders, as it pertains to an individual executive's personal stock transaction rather than operational or strategic changes.

Next Steps

• This document does not mention any specific future actions, events, or milestones for the company.

Key Dates

Recommendation

Keywords

Hims & Hers Health, HIMS, Oluyemi Okupe, CFO, insider trading, Form 4, stock sale, Rule 10b5-1, executive compensation, beneficial ownership